Daniela Lötsch

3.0k total citations
23 papers, 947 citations indexed

About

Daniela Lötsch is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Daniela Lötsch has authored 23 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Genetics and 9 papers in Oncology. Recurrent topics in Daniela Lötsch's work include Glioma Diagnosis and Treatment (10 papers), Meningioma and schwannoma management (3 papers) and Cancer Cells and Metastasis (3 papers). Daniela Lötsch is often cited by papers focused on Glioma Diagnosis and Treatment (10 papers), Meningioma and schwannoma management (3 papers) and Cancer Cells and Metastasis (3 papers). Daniela Lötsch collaborates with scholars based in Austria, Slovakia and Canada. Daniela Lötsch's co-authors include Walter Berger, Sabine Spiegl‐Kreinecker, Christine Pirker, Serge Weis, Josef Pichler, Sushilla van Schoonhoven, Gerald Webersinke, Matthias Preusser, Christine Marosi and Bahil Ghanim and has published in prestigious journals such as Blood, Cancer and British Journal of Cancer.

In The Last Decade

Daniela Lötsch

22 papers receiving 942 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniela Lötsch Austria 17 461 282 273 159 150 23 947
Kevin S. Choe United States 15 352 0.8× 314 1.1× 186 0.7× 143 0.9× 90 0.6× 31 1.0k
Sarah Beck Germany 16 534 1.2× 203 0.7× 62 0.2× 89 0.6× 56 0.4× 30 1.0k
Lea T. Berleau United States 10 1.1k 2.3× 238 0.8× 63 0.2× 375 2.4× 121 0.8× 11 1.7k
Josep Garcia Switzerland 12 473 1.0× 442 1.6× 471 1.7× 374 2.4× 80 0.5× 33 1.4k
Anh Tran United States 13 419 0.9× 173 0.6× 568 2.1× 369 2.3× 65 0.4× 20 1.0k
Joanna W. Ho Hong Kong 15 638 1.4× 283 1.0× 46 0.2× 281 1.8× 113 0.8× 16 1.1k
Katharina Seystahl Switzerland 16 230 0.5× 192 0.7× 434 1.6× 147 0.9× 207 1.4× 40 867
Tim Lautenschlaeger United States 17 529 1.1× 415 1.5× 271 1.0× 451 2.8× 64 0.4× 79 1.3k
Nikos E. Tsopanoglou Greece 18 362 0.8× 84 0.3× 125 0.5× 201 1.3× 29 0.2× 27 832
Caisheng Ye China 17 494 1.1× 237 0.8× 51 0.2× 282 1.8× 21 0.1× 29 976

Countries citing papers authored by Daniela Lötsch

Since Specialization
Citations

This map shows the geographic impact of Daniela Lötsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Lötsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Lötsch more than expected).

Fields of papers citing papers by Daniela Lötsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Lötsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Lötsch. The network helps show where Daniela Lötsch may publish in the future.

Co-authorship network of co-authors of Daniela Lötsch

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Lötsch. A scholar is included among the top collaborators of Daniela Lötsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Lötsch. Daniela Lötsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mayr, Lisa, Sibylle Madlener, J.M. Berger, et al.. (2023). HGG-08. COMBINATORIAL ACTIVITY OF CDK4/6-INHIBITORS AND TRAMETINIB IN PEDIATRIC HIGH-GRADE GLIOMA WITH BRAFV600E MUTATION AND HOMOZYGOUS CDKN2A DELETION. Neuro-Oncology. 25(Supplement_1). i40–i40.
2.
Mischkulnig, Mario, Barbara Kiesel, Daniela Lötsch, et al.. (2021). Heme Biosynthesis mRNA Expression Signature: Towards a Novel Prognostic Biomarker in Patients with Diffusely Infiltrating Gliomas. Cancers. 13(4). 662–662. 5 indexed citations
3.
Lötsch, Daniela, Dominik Kirchhofer, Sushilla van Schoonhoven, et al.. (2019). TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAFV600E/TERT promoter double-mutated glioma. Acta Neuropathologica Communications. 7(1). 128–128. 22 indexed citations
4.
5.
Spiegl‐Kreinecker, Sabine, Daniela Lötsch, Johannes Gojo, et al.. (2018). P02.10 Aggressiveness of meningiomas is predicted by cell immortalization in vitro and dependent on TERT promoter mutations. Neuro-Oncology. 20(suppl_3). iii274–iii274. 1 indexed citations
6.
Spiegl‐Kreinecker, Sabine, Daniela Lötsch, Johannes Gojo, et al.. (2018). TERTpromoter mutations are associated with poor prognosis and cell immortalization in meningioma. Neuro-Oncology. 20(12). 1584–1593. 85 indexed citations
7.
Erhart, Friedrich, Dieter Printz, Klara Soukup, et al.. (2018). Gliomasphere marker combinatorics: multidimensional flow cytometry detects CD44+/CD133+/ITGA6+/CD36+ signature. Journal of Cellular and Molecular Medicine. 23(1). 281–292. 27 indexed citations
8.
Englinger, Bernhard, Maximilian J. Mair, Walter Miklos, et al.. (2017). Loss of CUL4A expression is underlying cisplatin hypersensitivity in colorectal carcinoma cells with acquired trabectedin resistance. British Journal of Cancer. 116(4). 489–500. 13 indexed citations
9.
Riedl, Julia, Matthias Preusser, Florian Posch, et al.. (2017). Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism. Blood. 129(13). 1831–1839. 177 indexed citations
10.
Englinger, Bernhard, Daniela Lötsch, Christine Pirker, et al.. (2016). Acquired nintedanib resistance in FGFR1-driven small cell lung cancer: role of endothelin-A receptor-activated ABCB1 expression. Oncotarget. 7(31). 50161–50179. 18 indexed citations
11.
Terenzi, Alessio, Daniela Lötsch, Sushilla van Schoonhoven, et al.. (2016). Another step toward DNA selective targeting: NiIIand CuIIcomplexes of a Schiff base ligand able to bind gene promoter G-quadruplexes. Dalton Transactions. 45(18). 7758–7767. 52 indexed citations
12.
Sevelda, Florian, Lisa Mayr, Bernd Kubista, et al.. (2015). EGFR is not a major driver for osteosarcoma cell growth in vitro but contributes to starvation and chemotherapy resistance. Journal of Experimental & Clinical Cancer Research. 34(1). 134–134. 60 indexed citations
13.
Spiegl‐Kreinecker, Sabine, Daniela Lötsch, Bahil Ghanim, et al.. (2015). Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosis. Neuro-Oncology. 17(9). 1231–1240. 103 indexed citations
14.
Lötsch, Daniela, Bahil Ghanim, Gabriele Wurm, et al.. (2013). Prognostic significance of telomerase-associated parameters in glioblastoma: effect of patient age. Neuro-Oncology. 15(4). 423–432. 53 indexed citations
15.
Lötsch, Daniela, Elisabeth Steiner, Klaus Holzmann, et al.. (2013). Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axis. Oncotarget. 4(11). 1904–1918. 46 indexed citations
16.
Losert, Annemarie, Daniela Lötsch, Andreas Lackner, et al.. (2012). The major vault protein mediates resistance to epidermal growth factor receptor inhibition in human hepatoma cells. Cancer Letters. 319(2). 164–172. 29 indexed citations
17.
Preusser, Matthias, Sabine Spiegl‐Kreinecker, Daniela Lötsch, et al.. (2012). Trabectedin has promising antineoplastic activity in high‐grade meningioma. Cancer. 118(20). 5038–5049. 49 indexed citations
18.
Mathieu, Véronique, Christine Pirker, Wolfgang M. Schmidt, et al.. (2012). Aggressiveness of human melanoma xenograft models is promoted by aneuploidy-driven gene expression deregulation. Oncotarget. 3(4). 399–413. 45 indexed citations
19.
Pirker, Christine, Daniela Lötsch, Sabine Spiegl‐Kreinecker, et al.. (2010). Response of experimental malignant melanoma models to the pan‐Aurora kinase inhibitor VE‐465. Experimental Dermatology. 19(12). 1040–1047. 16 indexed citations
20.
Spiegl‐Kreinecker, Sabine, Christine Pirker, Martin Filipits, et al.. (2009). O6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patients. Neuro-Oncology. 12(1). 28–36. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kevin S. Choe Breakdown of academic impact, for papers by Sarah Beck Breakdown of academic impact, for papers by Lea T. Berleau Breakdown of academic impact, for papers by Josep Garcia Breakdown of academic impact, for papers by Anh Tran Breakdown of academic impact, for papers by Joanna W. Ho Breakdown of academic impact, for papers by Katharina Seystahl Breakdown of academic impact, for papers by Tim Lautenschlaeger Breakdown of academic impact, for papers by Nikos E. Tsopanoglou Breakdown of academic impact, for papers by Caisheng Ye
Rankless by CCL
2026